Insider Trading disclosures for Replimune Group Inc

The latest disclosure was made by Sushil Patel in Replimune Group Inc where a trade of 10,000 Common Stock done at an average price of $12.4 was reported to US exchanges on Dec. 16, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Sushil Patel	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 12.42 per share.	16 Dec 2024	10,000	202,014 (0%)	0%	12.4	124,200	Common Stock
Konstantinos Xynos	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 10.78 per share.	18 Nov 2024	7,246	109,885 (0%)	0%	10.8	78,112	Common Stock
Christopher Sarchi	Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 10.78 per share.	18 Nov 2024	5,207	87,045 (0%)	0%	10.8	56,131	Common Stock
Philip Astley-Sparke	Director, Executive Chairman	Gift of securities by or to the insider at price $ 0.00 per share.	30 Aug 2024	50,000	1,437,350 (3%)	0%		0	Common Stock
Emily Hill	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 10.18 per share.	16 Aug 2024	8,938	101,057 (0%)	0%	10.2	90,989	Common Stock
Konstantinos Xynos	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 7.50 per share.	07 Jun 2024	15,881	117,131 (0%)	0%	7.5	119,108	Common Stock
Philip Astley-Sparke	Director, Executive Chairman	Sale of securities on an exchange or to another person at price $ 6.47 per share.	16 May 2024	37,928	1,487,350 (4%)	0%	6.5	245,394	Common Stock
Robert Coffin	Director	Sale of securities on an exchange or to another person at price $ 6.47 per share.	16 May 2024	11,464	1,821,872 (4%)	0%	6.5	74,172	Common Stock
Colin Love	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 6.47 per share.	16 May 2024	17,615	777,345 (2%)	0%	6.5	113,969	Common Stock
Sushil Patel	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 6.47 per share.	16 May 2024	20,194	212,014 (0%)	0%	6.5	130,655	Common Stock
Konstantinos Xynos	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 6.47 per share.	16 May 2024	6,367	133,012 (0%)	0%	6.5	41,194	Common Stock
Andrew Schwendenman	Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 6.47 per share.	16 May 2024	2,298	38,238 (0%)	0%	6.5	14,868	Common Stock
Christopher Sarchi	Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 6.47 per share.	16 May 2024	2,218	92,252 (0%)	0%	6.5	14,350	Common Stock
Hyam I. Levitsky	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2024	32,000	32,000	-		-	Stock Option (right to buy)
Joseph P. Slattery	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2024	32,000	32,000	-		-	Stock Option (right to buy)
Paolo Pucci	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2024	32,000	32,000	-		-	Stock Option (right to buy)
Kapil Dhingra	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2024	32,000	32,000	-		-	Stock Option (right to buy)
Dieter Weinand	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2024	32,000	32,000	-		-	Stock Option (right to buy)
Emily Hill	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2024	80,000	80,000	-		-	Employee Stock Option (right to buy)
Emily Hill	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2024	26,665	109,995 (0%)	0%		0	Common Stock
Christy J. Oliger	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2024	32,000	32,000	-		-	Stock Option (right to buy)
Sushil Patel	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2024	83,335	232,208 (0%)	0%		0	Common Stock
Sushil Patel	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2024	250,000	250,000	-		-	Employee Stock Option (right to buy)
Konstantinos Xynos	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2024	26,665	139,379 (0%)	0%		0	Common Stock
Konstantinos Xynos	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2024	80,000	80,000	-		-	Employee Stock Option (right to buy)
Andrew Schwendenman	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2024	53,325	53,325	-		-	Employee Stock Option (right to buy)
Andrew Schwendenman	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2024	17,775	40,536 (0%)	0%		0	Common Stock
Veleka Peeples-Dyer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2024	32,000	32,000	-		-	Stock Option (right to buy)
Christopher Sarchi	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2024	66,675	66,675	-		-	Employee Stock Option (right to buy)
Christopher Sarchi	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2024	22,225	94,470 (0%)	0%		0	Common Stock
Pamela Esposito	Chief Business Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.30 per share.	22 Aug 2023	13,600	277,036 (0%)	0%	3.3	44,880	Common Stock
Pamela Esposito	Chief Business Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Aug 2023	5,000	35,750	-		-	Employee Stock Option (right to buy)
Pamela Esposito	Chief Business Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Aug 2023	13,600	91,691	-		-	Employee Stock Option (right to buy)
Pamela Esposito	Chief Business Officer	Sale of securities on an exchange or to another person at price $ 20.01 per share.	22 Aug 2023	18,600	263,436 (0%)	0%	20.0	372,186	Common Stock
Pamela Esposito	Chief Business Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.50 per share.	22 Aug 2023	5,000	282,036 (0%)	0%	15.5	77,500	Common Stock
Pamela Esposito	Chief Business Officer	Sale of securities on an exchange or to another person at price $ 20.00 per share.	11 Aug 2023	1,400	263,436 (0%)	0%	20	28,000	Common Stock
Pamela Esposito	Chief Business Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Aug 2023	1,400	105,291	-		-	Employee Stock Option (right to buy)
Pamela Esposito	Chief Business Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.30 per share.	11 Aug 2023	1,400	264,836 (0%)	0%	3.3	4,620	Common Stock
Pamela Esposito	Chief Business Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.50 per share.	10 Jul 2023	5,000	283,436 (0%)	0%	15.5	77,500	Common Stock
Pamela Esposito	Chief Business Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jul 2023	5,000	40,750	-		-	Employee Stock Option (right to buy)
Pamela Esposito	Chief Business Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jul 2023	15,000	106,691	-		-	Employee Stock Option (right to buy)
Pamela Esposito	Chief Business Officer	Sale of securities on an exchange or to another person at price $ 21.12 per share.	10 Jul 2023	2,077	263,436 (0%)	0%	21.1	43,866	Common Stock
Pamela Esposito	Chief Business Officer	Sale of securities on an exchange or to another person at price $ 21.63 per share.	10 Jul 2023	17,923	265,513 (0%)	0%	21.6	387,674	Common Stock
Pamela Esposito	Chief Business Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.30 per share.	10 Jul 2023	15,000	278,436 (0%)	0%	3.3	49,500	Common Stock
Tanya Lewis	Chief Dev. Op. Officer	Sale of securities on an exchange or to another person at price $ 24.10 per share.	13 Jun 2023	12,043	136,110 (0%)	0%	24.1	290,236	Common Stock
Tanya Lewis	Chief Dev. Op. Officer	Sale of securities on an exchange or to another person at price $ 23.45 per share.	13 Jun 2023	817	135,293 (0%)	0%	23.5	19,159	Common Stock
Sushil Patel	Chief Strategy Officer	Sale of securities on an exchange or to another person at price $ 24.11 per share.	13 Jun 2023	5,145	149,426 (0%)	0%	24.1	124,046	Common Stock
Sushil Patel	Chief Strategy Officer	Sale of securities on an exchange or to another person at price $ 23.44 per share.	13 Jun 2023	553	148,873 (0%)	0%	23.4	12,962	Common Stock
Veleka Peeples-Dyer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2023	50,400	50,400	-		-	Employee Stock Option (right to buy)
Tanya Lewis	Chief Dev. Op. Officer	Sale of securities on an exchange or to another person at price $ 18.05 per share.	16 May 2023	12,207	148,153 (0%)	0%	18.0	220,336	Common Stock

Showing 1 to 50 of 379 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

34.53% Fall from 52W High

Insider Trading disclosures for Replimune Group Inc

The latest disclosure was made by Sushil Patel in Replimune Group Inc where a trade of 10,000 Common Stock done at an average price of $12.4 was reported to US exchanges on Dec. 16, 2024.

Screeners based on Insider Trading and SAST parameters